Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma

Related Experiment Video

Updated: Sep 30, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Massimo Roncalli1, Paolo Bianchi, Barbara Bruni

  • 1Department of Pathology and Research Laboratory, Humanitas Clinical Institute of Rozzano and University of Milan, Italy. massimo.roncalli@humaitas.it

Hepatology (Baltimore, Md.)
|July 27, 2002
PubMed

Insights

Gene methylation inactivates cell cycle regulators in liver cancer. Early methylation occurs in cirrhosis, while advanced methylation indicates hepatocellular carcinoma (HCC), suggesting a stepwise progression in hepatic carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) involves altered cell cycle control, particularly RB1 gene-related pathways.
  • Investigating RB1 pathway gene methylation is crucial for understanding HCC development.

Purpose of the Study:

  • To investigate the inactivation patterns of p14ARF, p15INK4B, p16INK4A, p18INK4C, and RB1 genes via methylation in HCC and cirrhosis.
  • To determine if gene methylation patterns differ between cirrhosis and HCC.

Main Methods:

  • Analysis of promoter methylation in p14ARF, p15INK4B, p16INK4A, p18INK4C, and RB1 genes.
  • Studied 33 HCCs, adjacent cirrhotic tissues, and 6 HCC cell lines.
  • Correlated gene methylation with protein loss using immunocytochemistry.

Main Results:

  • Over 76% of cirrhoses and 94% of HCCs showed at least one methylated gene.
  • Cirrhosis more frequently exhibited one methylated gene (51%) compared to HCC (33%).
  • p16INK4A methylation was frequent in HCC (82%), while p15INK4B and p16INK4A were common in cirrhosis (33-39%).
  • Gene methylation correlated with protein loss, with complete loss in HCC and partial loss in cirrhosis.

Conclusions:

  • DNA methylation inactivation of RB1 pathway genes is common in both cirrhosis and HCC.
  • A stepwise progression of methylation, from early events in cirrhosis to advanced events in HCC, contributes to hepatic carcinogenesis.
  • Methylation patterns offer potential clinical implications for understanding cirrhosis-HCC progression.

More Related Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...